Author Correction: Adjuvant Nivolumab in Resected Stage IIB/C Melanoma: Primary Results from the Randomized, Phase 3 CheckMate 76K Trial
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.